Literature DB >> 663548

Plasma and urinary aldosterone and their interrelations with blood pressure, plasma renin activity and urinary electrolytes in normotensive subjects.

K Tolagen, B E Karlberg.   

Abstract

Plasma aldosterone (PA), urinary aldosterone excretion (Aldo-U), urinary sodium and potassium excretion and supine and sitting blood pressure (BP) were studied in 120 normotensive subjects. PA was determined after 1 h supine rest (basal PA), after ambulation for 3--4 h (upright PA) and after stimulation with 80 mg frusemide orally (stimulated PA). Aldo-U and urinary electrolytes were measured the day before the PA determinations. PA and Aldo-U were determined by specific radioimmunoassays. Basal PA rose approximately two-fold after upright posture and about three-fold after frusemide stimulation. However, there was a very wide scatter in PA values between individual subjects. A significant correlation existed between basal PA and Aldo-U (r = 0.42), P less than 0.001). Aldo-U decreased with increasing age. The PA values correlated fairly well with the concomitant values for plasma renin activity (r = 0.26--0.40, P less than 0.004 for basal PRA and P less than 0.001) for both upright and stimulated PRA). No relationships could be found between Aldo-U and urinary electrolyte excretions. No correlations were observed between aldosterone and BP.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 663548     DOI: 10.3109/00365517809108418

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

Review 1.  Aldosterone and arterial hypertension.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Barbara Obermayer-Pietsch; Thomas R Pieber
Journal:  Nat Rev Endocrinol       Date:  2009-12-22       Impact factor: 43.330

2.  Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.

Authors:  U Dahlström; B E Karlberg
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Long-term experience of captopril in the treatment of primary (essential) hypertension.

Authors:  B E Karlberg; J Asplund; S Wettre; K P Ohman; O R Nilsson
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.

Authors:  Marisa K Ames; Clarke E Atkins; Andrea C Lantis; James zum Brunnen
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-03-23       Impact factor: 1.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.